An 8-year retrospective study of patients suffering a central retinal
vein occlusion (CRVO) was undertaken to study secondary new vessel for
mation and whether pathologies known to predispose to CRVO influenced
the occurrence of these neovascular complications and their responsive
ness to treatment. Seventy-three patients were studied. Ocular neovasc
ularisation had occurred in 60%. More specifically 39% developed neova
scular glaucoma. Panretinal photocoagulation produced regression in on
ly 37% of those with established neovascularisation and was unsuccessf
ul in preventing neovascularisation in five patients treated prophylac
tically. Patients with pre-existing primary open angle glaucoma (POAG)
were statistically more likely to develop ocular neovascularisation (
p = 0.02), which was also less responsive to laser therapy (p = 0.02).
Adequate prior glaucoma therapy did not protect against this enhanced
complication rate. It was concluded that POAG is a significant risk f
actor for developing ocular neovascularisation after CRVO which will b
e refractory to laser therapy.